ELISA Kit for Galectin 9 (GAL9)

LGALS9; Ecalectin; Lectin,Galactoside-Binding Soluble 9; Tumor antigen HOM-HD-21

Specificity

This assay has high sensitivity and excellent specificity for detection of Galectin 9 (GAL9).
No significant cross-reactivity or interference between Galectin 9 (GAL9) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Galectin 9 (GAL9) and the recovery rates were calculated by comparing the measured value to the expected amount of Galectin 9 (GAL9) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 96-104 101
EDTA plasma(n=5) 87-101 90
heparin plasma(n=5) 87-97 93

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Galectin 9 (GAL9) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Galectin 9 (GAL9) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Galectin 9 (GAL9) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 93-105% 95-102% 84-91% 79-101%
EDTA plasma(n=5) 78-91% 86-96% 88-102% 95-103%
heparin plasma(n=5) 95-104% 88-95% 81-90% 82-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
Detection Reagent B 1×120µL Assay Diluent B 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
American Journal of Nephrology Temporal Increases in Urinary Carboxymethyllysine Correlate with Albuminuria Development in Diabetes Karger: 328581
Clinical Immunology Galectin-9 administration ameliorates CVB3 induced myocarditis by promoting the proliferation of regulatory T cells and alternatively activated Th2 cells ScienceDirect: S1521661611001057
Renal Failure Rat Renal Interstitial Fibroblasts Affect the Th1/Th2 Profile In Vitro Pubmed: 22013937
BMC Nephrol Serum galectin-9 levels are elevated in the patients with type 2 diabetes and chronic kidney disease PubMed: 23339460
Retrovirology Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection PubMed: PMC3750478
PLoS One. Upregulation of the Tim-3/Galectin-9 Pathway of T Cell Exhaustion in Chronic Hepatitis B Virus Infection PubMed: PMC3480425
PLoS Pathogens Galectin-9 and IL-21 Mediate Cross-regulation between Th17 and Treg Cells during Acute Hepatitis C PubMed: PMC3688567
PLOS ONE Graves’ Disease Is Associated with a Defective Expression of the Immune Regulatory Molecule Galectin-9 in Antigen-Presenting Dendritic Cells PubMed: 25880730
Advances in Experimental Medicine and Biology Molecules of Damage-Associated Patterns in Bronchoalveolar Lavage Fluid and Serum in Chronic Obstructive Pulmonary Disease Pubmed:29429028
Journal of Microbiology, Immunology and Infection Galectin-9-like from Angiostrongylus cantonensis young adult worms modulates eosinophil chemotaxis in vitro Doi: 10.1016/j.jmii.2018.09.010
Oncology Letters The effects of Tim‑3 activation on T‑cells in gastric cancer progression
Scientific Reports Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra … Pubmed: 31337865
Biomolecules Blood Levels of Galectin-9, an Immuno-Regulating Molecule, Reflects the Severity for the Acute and Chronic Infectious Diseases. Biomolecules 2021, 11, 430 33804076
Medicine Regulatory T cells, damage-associated molecular patterns, and myeloid-derived suppressor cells in bronchoalveolar lavage fluid interlinked with chronic obstructive … Pubmed:35687771
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA309Hu01 Recombinant Galectin 9 (GAL9) Positive Control; Immunogen; SDS-PAGE; WB.
APA309Hu01 Active Galectin 9 (GAL9) Cell culture; Activity Assays.
APA309Hu61 Active Galectin 9 (GAL9) Cell culture; Activity Assays.
EPA309Hu61 Eukaryotic Galectin 9 (GAL9) Positive Control; Immunogen; SDS-PAGE; WB.
PAA309Hu01 Polyclonal Antibody to Galectin 9 (GAL9) WB; IHC
MAA309Hu22 Monoclonal Antibody to Galectin 9 (GAL9) WB; IHC; ICC; IP.
SEA309Hu ELISA Kit for Galectin 9 (GAL9) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA309Hu CLIA Kit for Galectin 9 (GAL9) Chemiluminescent immunoassay for Antigen Detection.
LMA309Hu Multiplex Assay Kit for Galectin 9 (GAL9) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.